Like most websites, we use cookies and other similar technologies for a number of reasons, such as keeping our website reliable and secure, personalizing content, providing social media features and to better understand how our site is used. By using our site, you are agreeing to our use of these tools. Please review our Privacy Policy to learn more. 

Skip to Content

For everyone's safety, masks are required for everyone in our facilities. This includes visitors and patients. View visitor policy.

the beat

The Beat:
A Bryan Heart Blog

The Beat is a monthly blog from Bryan Heart cardiologists to keep you informed on trending topics, advancements and news in heart care.

Subscribe to receive The Beat to your inbox monthly.

Bryan Heart

To refer a patient to a Bryan Heart cardiologist or surgeon, call 402-483-3333.

Learn about Bryan Heart

Preventative Measures to Reduce Heart Disease

Written by Bryan Heart Cardiologist, John Steuter, MD

Heart disease is the leading cause of death in the United States and has carried the number one spot for many years. Yet, heart disease deaths are steadily decreasing in many states and cancer is gradually becoming the leading cause of death.   

leading cause of death in each state: united states

Improved Heart Disease Prevention

This decrease in heart disease deaths is largely due to improved measures in prevention. HOPE-3, a study focused on preventing heart disease before it starts, is showing measurable outcomes.

HOPE-3 assessed outcomes of preventative treatment with cholesterol and blood pressure lowering drugs. The study includes in large globally diverse populations at intermediate risk of heart disease.

How it worked:
Participants were assigned to one of four groups:

  1. Crestor 10mg plus a combination pill of candesartan 16mg and HCTZ 12.5 daily
  2. Crestor 10mg and placebo daily
  3. Placebo pill plus candesartan/HCTZ daily
  4. Two placebo pills

The participants were followed for five years. 

Study Outcomes 

The study showed a 30% reduction in heart disease risk for those taking Crestor and a combination pill of candesartan and HCTZ daily (control group 1). The results were shared at the American College of Cardiology in April. This study continues to build on our knowledge of prevention strategies with control of blood pressure and cholesterol and proves prevention decreases heart disease deaths. 

Other Heart Disease Study Outcomes 

  • Statin Arm
    The use of statin arm showed significant reduction in heart disease events, but blood pressure lowering drugs alone did not show noteworthy improvement. This study reaffirms the benefit and importance of statin in reducing heart disease deaths.
    The SPRINT study found an improvement in outcomes with aggressive blood pressure control with a goal of 120/80. This study focused on patients of elevated risk, as opposed to HOPE-3 which focused on patients of intermediate risk and can likely explain the differences in results between the two studies.

Overall, prevention works to decrease heart disease deaths and continued work in this area will benefit us all.

At Bryan Heart, we continue to stay informed on national leading edge research. If you have questions about heart disease prevention or would like to refer a patient, call 402-483-3333. 

steuter john

About John Steuter, MD

John Steuter, MD, is a cardiologist at Bryan Heart. Steuter is a graduate of The University of Nebraska Medical Center College of Medicine and joined Bryan Heart in 2015 after completing his residency and fellowship at The University of Nebraska Medical Center. He is certified with the American Board of Internal Medicine.

View Dr. Steuter’s physician profile


Copyright 2022 Bryan Health. All rights reserved.